Viewing Study NCT00397904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-01 @ 7:37 AM
Study NCT ID: NCT00397904
Status: COMPLETED
Last Update Posted: 2015-11-25
First Post: 2006-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the esophagus View
None squamous cell carcinoma of the esophagus View
None recurrent esophageal cancer View
None recurrent gastric cancer View
None adenocarcinoma of the stomach View
None stage IV esophageal cancer View
None stage IV gastric cancer View